Skin Boosters vs Dermal Fillers: What's the Difference?
Both contain hyaluronic acid, but they do completely different things. A physician explains the distinction, when each is appropriate, and how to think about these treatments for skin affected by hormonal change.
This content is for informational purposes only and does not constitute medical advice. Results may vary. A consultation is required before any injectable treatment.
One of the most common points of confusion I encounter in consultations is the difference between skin boosters and dermal fillers. Both are injectable treatments. Both contain hyaluronic acid. Both are sometimes described as improving skin quality. But they are clinically distinct products designed for fundamentally different purposes — and understanding the distinction helps patients make informed decisions about their care.
Dermal Fillers: Structure and Volume
Dermal fillers are formulated to provide structural support. They contain hyaluronic acid that has been cross-linked — chemically bonded into a denser, more cohesive gel that resists degradation and maintains its shape under pressure. This cross-linking is what makes a dermal filler a filler: it can be placed in a specific anatomical location to add volume, define contour, or support overlying tissue.
Common uses include:
- Restoring volume loss in the cheeks and mid-face
- Defining the jawline or chin
- Augmenting the lips
- Softening deep nasolabial folds or marionette lines
The result of filler treatment is visible relatively quickly — often immediately, with the full result apparent once any swelling subsides. The structural effect can last anywhere from 9 to 18 months depending on the product used, the area treated, and individual metabolism.
For menopausal patients, facial volume loss is a significant concern. Oestrogen decline reduces subcutaneous fat distribution and accelerates bone remodelling, leading to the characteristic hollowing of the temples, cheeks, and under-eye areas that many women notice in their late 40s and 50s. Dermal fillers address this volume deficit directly.
Skin Boosters: Quality and Hydration
Skin boosters contain hyaluronic acid that has been minimally or specially cross-linked — formulated not to hold a shape but to integrate into the dermis and improve the skin's intrinsic quality. Products like Profhilo and Restylane Skinboosters are injected in small depots across the treatment area, where they spread into the dermal tissue and:
- Dramatically improve skin hydration from within
- Stimulate fibroblast activity and collagen production
- Improve skin elasticity and surface texture
- Restore some of the depleted dermal HA content that oestrogen deficiency causes
The effect of skin boosters is a luminous, hydrated, more even-textured complexion — not a volumisation. Patients often describe the result as their skin looking rested, healthy, and "like itself but better." There is no structure added; the improvement is in skin quality.
Profhilo, in particular, has a unique formulation: it uses uncross-linked HA at a high concentration, which results in a bio-remodelling effect — it biostimulates collagen and elastin production — rather than simply hydrating. This makes it a hybrid between a skin booster and a collagen stimulator.
When to Choose Which
The decision between skin boosters and fillers depends on what the patient needs:
Choose skin boosters when:
- The primary concern is skin quality — dullness, dryness, fine surface texture, loss of elasticity
- The patient wants to restore natural-looking luminosity without adding visible volume
- You are treating areas where volumisation would look unnatural (neck, décolletage, backs of hands)
- You want to improve the overall health of the skin as a foundation before other treatments
Choose dermal fillers when:
- There is visible volume loss that changes the shape or proportions of the face
- Deep structural lines or folds require support
- Specific anatomical augmentation is the goal (lip shape, chin projection, cheek definition)
Use both when:
- Many patients benefit from skin boosters to restore quality and fillers to restore structure — these are complementary rather than competing treatments
- The consultation will identify whether the patient's concerns are primarily about quality, volume, or both
A Word on Sequential Treatment
We often recommend beginning with skin boosters, particularly for patients who are new to injectable treatments or who have significant skin quality concerns. Skin boosters improve the underlying canvas — increasing hydration, stimulating collagen, improving elasticity — which means that any subsequent filler treatment performs better and results are more natural-looking.
Injecting filler into severely dehydrated, thin skin is analogous to plastering over a crumbling wall. The filler settles differently, the result is less elegant, and the longevity may be reduced. Skin that is hydrated, thick, and structurally healthy holds filler more predictably and for longer.
The Consultation at London & Glow
At London & Glow, we do not recommend treatments based on patient preference alone. We conduct a thorough assessment of facial structure, skin quality, and patient goals before recommending a treatment pathway. Many patients come in certain they need filler and leave with a plan that begins with skin boosters — not because we are withholding treatment, but because the clinical priority is different from what they assumed.
This is one of the genuine advantages of physician-led care: the assessment comes before the recommendation, not after.
References
- Nikolis A, Aron JM. (2017). Evaluating the role of small particle hyaluronic acid fillers using micro-injection technique in the lower face. Clinical, Cosmetic and Investigational Dermatology, 10:233–42.
- Sparavigna A, et al. (2015). Antiageing, photoprotective and brightening activity in biorevitalizing cosmetics. Clinical, Cosmetic and Investigational Dermatology, 8:327–39.
- Rzepecki AK, et al. (2019). Estrogen-deficient skin. Menopause Review, 18(1):57–65.
- Tremaine AM, et al. (2012). Long-term outcomes with hyaluronic acid fillers. Dermatologic Surgery, 38(7):1115–21.